ERIN OROZCO: Open Payments
NPI 1265094650 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,088 in 172 payments from 27 companies in 2025. Trend: 2023 $602 · 2024 $1,068 · 2025 $4,088
Food & beverage: $3,989Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $917 |
| Madrigal Pharmaceuticals | 21 | $688 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $445 |
| Janssen Biotech, Inc. | 6 | $376 |
| Ardelyx, Inc. | 15 | $343 |
| PFIZER INC. | 11 | $159 |
| QOL Medical, LLC | 8 | $149 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Phathom Pharmaceuticals, Inc. | 11 | $86 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, IBSRELA, VIBERZI, CREON, LINZESS, SKYRIZI.
Industry payments across CT — which companies pay providers there.
